THE FDA JUST ISSUED A WARNING “NOBODY UNDER 18 SHOULD GET THE SHOT” AND PEOPLE ARE….
THREE PERCENTER NATION | By JohnR | May 11, 2022
On Thursday, The Food and Drug Administration (FDA) put limits on the Johnson & Johnson COVID-19 vaccine due to the rare risk of blood clots.
The FDA said in a statement:
“Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 vaccine because they would otherwise not receive a COVID-19 vaccine.”
A thorough study of the effects of the J&J COVID-19 vaccine was made and discovered a total of 60 cases, including nine deaths, of the clotting condition known as thrombosis with thrombocytopenia syndrome, or TTS, among the millions of people who got the J&J shot.
The FDA added:
“After conducting an updated analysis, evaluation and investigation of reported cases, the FDA has determined that the risk of thrombosis with thrombocytopenia syndrome (TTS), a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets with onset of symptoms approximately one to two weeks following administration of the Janssen Covid-19 vaccine, warrants limiting the authorisd use of the vaccine.”
Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a statement:
“We recognize that the Janssen COVID-19 Vaccine still has a role in the current pandemic response in the United States and across the global community. Our action reflects our updated analysis of the risk of TTS following administration of this vaccine and limits the use of the vaccine to certain individuals.”
UPI News noted:
“The FDA temporarily paused the administration of the Johnson & Johnson COVID-19 vaccine last year after several reported cases of blood clotting. At the time, all six cases were found in women between the ages of 18 and 48. At least one died.”
It is not the only serious side effect of Covid vaccines that have been verified this week. An MIT study found that there was an increased risk of side effects among 16-39 year-olds in Israel.
Just the News reported:
“COVID-19 vaccination was ‘significantly associated’ with a 25% jump in emergency medical services (EMS) for heart problems in 16-39 year-olds in Israel, whose vaccination rate is among the world’s highest, according to a peer-reviewed study by MIT researchers.”
Here’s what the study says:
“While not establishing causal relationships, the findings raise concerns regarding vaccine-induced undetected severe cardiovascular side-effects and underscore the already established causal relationship between vaccines and myocarditis, a frequent cause of unexpected cardiac arrest in young individuals.”
Initially, health authorities and experts said J&J’s vaccine would be an important tool for vaccinating residents of poor countries with large rural populations, as its one-dose regimen often makes it easier to administer in far-flung locations.
The vaccine also can be stored at higher temperatures than the Pfizer-BioNTech and Moderna vaccines.
Yet the safety concerns, combined with manufacturing problems that limited supply, have diminished the role of J&J’s vaccine. Sales of the vaccine—which has a relatively low, not-for-profit price—were $2.4 billion for 2021. J&J recently withdrew its previous forecast of $3 billion in sales for 2022, citing a global surplus of doses and uncertain demand.
Sources: Trendingpolitics, CNBC, NBC, Fox
